MSD will build a new manufacturing facility at the company’s newly acquired Dunboyne Biologics campus in Co. Meath it was announced yesterday.
The new facility is expected to create an estimated 140 new jobs by 2025 and will support an innovative new approach to developing and launching MSD’s future biologics medicines. Additionally, the existing MSD Dunboyne Biologics facility expect to hire approximately 100 new employees within the coming year.
MSD Ireland first established here over 50 years ago. MSD currently employs approximately 2,700 employees, across six sites in Ballydine, Co Tipperary, Brinny, Co Cork, Carlow, Dunboyne, Co. Meath and Dublin and, in addition, operate substantial Human Health and Animal Health businesses.
The company says co-locating this new facility beside an existing plant will support greater innovation and collaboration between MSD’s research and manufacturing teams, which will significantly accelerate the time it takes to bring a medicine to market benefiting patients world-wide. Planning and design of the facility will commence immediately, with the aim of completing construction and commencing operations in 2023.
welcoming the news, An Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar said, "I warmly welcome the announcement by MSD Ireland that it will build a new manufacturing facility at its Dunboyne Biologics campus. This important investment will directly create 140 new jobs by 2025 and a further 100 will also be hired in the existing facility on the site over the coming year. These 240 new jobs are a really welcome boost for Meath I wish MSD the very best with the project."